Blood-Grouping Reagents Market Size, Share, and Outlook, H2-2025 Report- By Technique (PCRbased and microarray techniques, Assaybased techniques, Massively parallel sequencing techniques, Serology ), By End-User (Hospitals and blood banks, Clinical labora

Blood-Grouping Reagents Market Outlook
The global Blood-Grouping Reagents Market Size is valued at $2.3 Billion in 2025 and is forecast to reach $4.1 Billion in 2032 at a CAGR of 8.6%.
The Blood-Grouping Reagents Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Blood-Grouping Reagents Market segments across 22 countries from 2021 to 2032. Key segments covered include By Technique (PCRbased and microarray techniques, Assaybased techniques, Massively parallel sequencing techniques, Serology ), By End-User (Hospitals and blood banks, Clinical laboratories, Academic and research institutes), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.

Blood-Grouping Reagents Market Insights, 2025
The blood-grouping reagents market in 2025 is marked by significant automation advances and multiple high-profile FDA clearances. On June 17, 2025, Grifols received U.S. clearance for its Erytra and Erytra Eflexis fully automated immunohematology analyzers, capable of performing ABO/Rh typing, antibody screening, identification, titration, direct antiglobulin testing, and compatibility checks using DG Gel 8 cards. The same approval included the DG Gel 8 Neutral card for antibody detection and control, expanding the automation capabilities of transfusion services. Earlier in January 2025, Immucor’s Echo Lumena and Galileo Echo platforms were cleared in the U.S., further enhancing throughput and standardization in antibody detection workflows. Complementary software updates and hardware enhancements, such as Fresenius Kabi’s Aurora Xi system, are reinforcing the shift toward fully integrated, LIS-connected blood bank operations. With regulatory pathways now clearer, many integrated delivery networks are standardizing on dual-platform strategies to secure reagent supply continuity and redundancy, while also specifying image capture, ISBT-128 compliance, and QC kit integration as part of procurement requirements.

Five Trends Shaping the Global Blood-Grouping Reagents Market in 2025 and Beyond
The global Blood-Grouping Reagents Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.

What are the Biggest Opportunities for Growth in the Blood-Grouping Reagents Industry?
The Blood-Grouping Reagents Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Blood-Grouping Reagents Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.

Blood-Grouping Reagents Market Segment Insights
The Blood-Grouping Reagents Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Technique (PCRbased and microarray techniques, Assaybased techniques, Massively parallel sequencing techniques, Serology ), By End-User (Hospitals and blood banks, Clinical laboratories, Academic and research institutes). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.

Blood-Grouping Reagents Industry Value Chain
The chapter identifies potential companies and their operations across the global Blood-Grouping Reagents Industry ecosystem. It assists decision-makers in evaluating global Blood-Grouping Reagents Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.

Scenario Analysis and Forecasts
Strategic planning in the Blood-Grouping Reagents Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.

Asia Pacific Blood-Grouping Reagents Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Blood-Grouping Reagents Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.

United States Blood-Grouping Reagents Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Blood-Grouping Reagents Market.

Europe Blood-Grouping Reagents Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Blood-Grouping Reagents Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Blood-Grouping Reagents Industry competitiveness. The report analyses the key Blood-Grouping Reagents Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.

Latin American Blood-Grouping Reagents Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Blood-Grouping Reagents Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.

Middle East and Africa Blood-Grouping Reagents Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Blood-Grouping Reagents Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.

Competitive Landscape – How Blood-Grouping Reagents Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Blood-Grouping Reagents Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Arena Bio Scien, Atlas Medical GmbH, AXO Science, BAG Diagnostics GmbH, Bio Rad Laboratories Inc, Calibre Scientific Inc, Danaher Corp, DIAGAST SAS, Grifols SA, Haemokinesis Ltd, Merck KGaA, Mesa Laboratories Inc, Novacyt SA, QuidelOrtho Corp, Quotient Ltd, Rapid Labs Ltd, Torax Biosciences Ltd, Tulip Diagnostics Pvt. Ltd, Werfenlife SA. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.

Blood-Grouping Reagents Market Scope
Leading Segments
By Technique
PCRbased and microarray techniques
Assaybased techniques
Massively parallel sequencing techniques
Serology
By End-User
Hospitals and blood banks
Clinical laboratories
Academic and research institutes

Leading Companies
Arena Bio Scien
Atlas Medical GmbH
AXO Science
BAG Diagnostics GmbH
Bio Rad Laboratories Inc
Calibre Scientific Inc
Danaher Corp
DIAGAST SAS
Grifols SA
Haemokinesis Ltd
Merck KGaA
Mesa Laboratories Inc
Novacyt SA
QuidelOrtho Corp
Quotient Ltd
Rapid Labs Ltd
Torax Biosciences Ltd
Tulip Diagnostics Pvt. Ltd
Werfenlife SA

Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Reasons to Buy the Report

Make informed decisions with 12-year forecasts across 22 countries and multiple market segments.

Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry.

Gain insights into the competitive landscape, including company profiles, financials, and strategic moves.

Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations.

Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade.

Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions.

Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.

Show more